Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ledovskikh, Arina
NCT05216497: Efficacy and Safety of Ingavirin®, 90 mg Capsules in Patients With COVID-19	Completed	3	233	RoW	Ingavirin®, 90 mg capsules, Placebo	Valenta Pharm JSC	COVID-19	01/22	04/22
NCT04940182: A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19	Completed	3	274	RoW	XC221, Placebo	RSV Therapeutics LLC	Sars-CoV-2 Infection	08/22	11/22